How to buy Midatech Pharma stock

Midatech Pharma plc is a biotechnology business based in the US. Midatech Pharma shares (MTP) are listed on the NASDAQ and all prices are listed in US Dollars. Midatech Pharma employs 65 staff and has a market cap (total outstanding shares value) of USD$29.6 million.

How to buy shares in Midatech Pharma

1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
3. Search for Midatech Pharma. Find the stock by name or ticker symbol: MTP. Research its history to confirm it's a solid investment against your financial goals.
4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Midatech Pharma reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
5. Decide on how many to buy. Weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Midatech Pharma, depending on your broker.
6. Check in on your investment. Congratulations, you own a part of Midatech Pharma. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Our top pick for

Beginners

Robinhood

Our top pick for

Building a portfolio

Sofi Invest

Our top pick for

Advanced traders

Interactive Brokers

How we chose our top picks

We evaluate stock trading platforms against a range of metrics that include fees, ease of use, available securities and advanced tools to meet specific investor needs. We encourage you to compare stock platforms to find one that's best for your particular budget and goals.

• Our pick for beginners. We chose Robinhood for this category because it offers commission-free trading and is easy to use. You can search for stocks by company name, and the mobile app is clean and intuitive to use.
• Our pick for building a portfolio. We chose SoFi for this category because it offers both commission-free stocks and a free robo-advisor. That means you can open an active investing account to pick and choose companies you want to invest in, and open a robo-advisor account to help you build a portfolio and manage how much risk you take on.
• Our pick for active traders. We picked Interactive Brokers for this category because it offers advanced tools and low fees for active investors and pros. The simpler IBKR Lite platform is aimed at less-active investors, but all users older than 21 must meet a $20,000 liquid net worth requirement for a cash account.

What's in this guide?

1. MTP shares summary
2. Compare share dealing platforms
3. Is MTP stock a buy or sell?
4. Stock performance over time
5. Can I short MTP shares?
6. Midatech Pharma's financials
7. How volatile are MTP shares?
8. Does Midatech Pharma pay a dividend?
9. Have MTP shares ever split?
10. Other common questions

Midatech Pharma share price

Use our graph to track the performance of MTP stocks over time.

Midatech Pharma shares at a glance

• Key figures

Information last updated 2021-02-23.

52-week range	USD$0.862 - USD$4.48
50-day moving average	USD$2.4971
200-day moving average	USD$2.0953
Wall St. target price	N/A
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	USD$-0.848

Buy Midatech Pharma shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

Sort by:

Name	Product	Stock trade fee	Asset types	Option trade fee	Annual fee	Signup bonus
Robinhood		$0	Stocks, Options, ETFs, Gold/Commodities	$0	0%	Free stock (chosen randomly with a value anywhere between $2.50 and $200) Sign up using the "go to site" link	Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.	Go to site More Info		loading Fetching your data...
Interactive Brokers		$0	Stocks, Bonds, Options	$0 + $0.65/contract, $1 minimum	0%	N/A	IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.	Go to site More Info		loading Fetching your data...
Tastyworks		$0	Stocks, Options, Cryptocurrency	Stocks & ETFs: $1/contract to open, $0 to close, $10 max/leg Futures: $2.50/contract to open, $0 to close	0%	Get 100 shares of stock (worth $1 to $6 a share) Open and fund a new cash or margin account with $2,000+	Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.	Go to site More Info		loading Fetching your data...
Moomoo		$0 for US stocks	Stocks, Options, ETFs	$0		N/A	Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.	Go to site More Info		loading Fetching your data...
TradeStation		$0	Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency	$0 + $0.50/contract		$50 Deposit qualifying assets of $5,000+	A platform built for all kinds of traders and all styles of trading	Go to site More Info		loading Fetching your data...

loading

Compare up to 4 providers

Clear selection

Compare

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Midatech Pharma stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of Midatech Pharma plc by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Shorting Midatech Pharma shares

There are currently 108,824 Midatech Pharma shares held short by investors – that's known as Midatech Pharma's "short interest". This figure is 1.3% up from 107,480 last month.

There are a few different ways that this level of interest in shorting Midatech Pharma shares can be evaluated.

Midatech Pharma's "short interest ratio" (SIR)

Midatech Pharma's "short interest ratio" (SIR) is the quantity of Midatech Pharma shares currently shorted divided by the average quantity of Midatech Pharma shares traded daily (recently around 640141.17647059). Midatech Pharma's SIR currently stands at 0.17. In other words for every 100,000 Midatech Pharma shares traded daily on the market, roughly 170 shares are currently held short.

However Midatech Pharma's short interest can also be evaluated against the total number of Midatech Pharma shares, or, against the total number of tradable Midatech Pharma shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Midatech Pharma's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Midatech Pharma shares in existence, roughly 10 shares are currently held short) or 0% of the tradable shares (for every 100,000 tradable Midatech Pharma shares, roughly 0 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Midatech Pharma.

Find out more about how you can short Midatech Pharma stock.

Have Midatech Pharma's shares ever split?

Midatech Pharma's shares were split on a 1:5 basis on 3 March 2020. So if you had owned 5 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Midatech Pharma shares – just the quantity. However, indirectly, the new 400% higher share price could have impacted the market appetite for Midatech Pharma shares which in turn could have impacted Midatech Pharma's share price.

Midatech Pharma share price volatility

Over the last 12 months, Midatech Pharma's shares have ranged in value from as little as $0.862 up to $4.48. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Midatech Pharma's is 1.6957. This would suggest that Midatech Pharma's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Midatech Pharma overview

Midatech Pharma plc focuses on the research and development of oncology and rare disease products in the United Kingdom, rest of Europe, and internationally. The company is developing MTD201, a long acting dose of Octreotide for the treatment of acromegaly and neuroendocrine tumors; and MTX110, a direct delivery treatment for diffuse intrinsic pontine glioma. It also offers drug delivery platforms, such as Q-Sphera, a microencapsulation and polymer-depot sustained release drug delivery platform; MidaSolve, an oligosaccharide nanotechnology used to solubilize drugs so that they can be administered in liquid form directly and locally into tumors; and MidaCore, a gold nanoparticle used for targeting sites of disease by using chemotherapeutic agents or immunotherapeutic agents. Midatech Pharma plc was founded in 2000 and is headquartered in Cardiff, the United Kingdom.

Frequently asked questions

• What percentage of Midatech Pharma is owned by insiders or institutions?

  Currently 0.212% of Midatech Pharma shares are held by insiders and 3.07% by institutions.

• How many people work for Midatech Pharma?

  Latest data suggests 65 work at Midatech Pharma.

• When does the fiscal year end for Midatech Pharma?

  Midatech Pharma's fiscal year ends in December.

• Where is Midatech Pharma based?

  Midatech Pharma's address is: Oddfellows House, Cardiff, United Kingdom, CF24 0AA

• What is Midatech Pharma's ISIN number?

  Midatech Pharma's international securities identification number is: US59564R3021

• What is Midatech Pharma's CUSIP number?

  Midatech Pharma's Committee on Uniform Securities Identification Procedures number is: 59564R104